MUHAMMAD KHAN: Open Payments
NPI 1215234737 · HAYWARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 25 payments from 13 companies in 2025. Trend: 2023 $615 · 2024 $903 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Amgen Inc. | 2 | $62 |
| Kowa Pharmaceuticals America, Inc. | 3 | $55 |
| Cipher Pharmaceuticals US LLC | 1 | $44 |
| Edwards Lifesciences Corporation | 1 | $39 |
| Ardelyx, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $29 |
| Novo Nordisk Inc | 1 | $25 |
Products named: Kerendia, REXULTI, MOUNJARO, ZORYVE, Natroba, SAPIEN 3 Ultra RESILIA, OTEZLA, IBSRELA.
Industry payments across CA — which companies pay providers there.
